All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of store-operated calcium channel activity | GO_1901340 | [Any process that stops, prevents or reduces the frequency, rate or extent of store-operated calcium channel activity.] |
| negative regulation of cation channel activity | GO_2001258 | [Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity.] |
| negative regulation of calcium ion transmembrane transporter activity | GO_1901020 | [Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion transmembrane transporter activity.] |
| negative regulation of voltage-gated calcium channel activity | GO_1901386 | [Any process that stops, prevents or reduces the frequency, rate or extent of voltage-gated calcium channel activity.] |
| positive regulation of voltage-gated calcium channel activity | GO_1901387 | [Any process that activates or increases the frequency, rate or extent of voltage-gated calcium channel activity.] |
| regulation of transforming growth factor beta activation | GO_1901388 | [Any process that modulates the frequency, rate or extent of transforming growth factor beta activation.] |
| regulation of transforming growth factor beta production | GO_0071634 | [Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta.] |
| transforming growth factor beta activation | GO_0036363 | [The release of transforming growth factor beta (TGF-beta) from its latent state. TGF-beta is secreted as part of a large latent complex (LLC) that is targeted to the extracellular matrix. Release of TGFbeta from its latent state is required for TGFbeta to bind to its receptors, and can occur by a variety of mechanisms.] |
| negative regulation of transforming growth factor beta activation | GO_1901389 | [Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta activation.] |
| negative regulation of transforming growth factor beta production | GO_0071635 | [Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta.] |
| primary oocyte stage | GO_0048159 | [The stage in oogenesis when the oocyte has a nucleus slightly larger than those of the adjacent cells and is surrounded by a layer of loose squamous epithelial cells.] |
| mammalian oogenesis stage | GO_0022605 | [A reproductive process that is a step in the formation and maturation of an ovum or female gamete from a primordial female germ cell.] |
| GO_0048157 | GO_0048157 | |
| oogonium stage | GO_0048158 | [The stage in mammalian oogenesis when the primordial germ cell is hardly distinguishable from other cortical cells of the ovary.] |
| obsolete hyperphosphorylation | GO_0048151 | [OBSOLETE. The excessive phosphorylation of a protein, as a result of activation of kinases, deactivation of phosphatases, or both.] |
| S100 beta biosynthetic process | GO_0048152 | [The chemical reactions and pathways resulting in the formation of S100 beta protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.] |
| positive regulation of transforming growth factor beta activation | GO_1901390 | [Any process that activates or increases the frequency, rate or extent of transforming growth factor beta activation.] |
| positive regulation of transforming growth factor beta production | GO_0071636 | [Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta.] |
| behavioral response to ether | GO_0048150 | [Any process that results in a change in the behavior of an organism as a result of an ether stimulus.] |
| adult behavior | GO_0030534 | [Behavior in a fully developed and mature organism.] |